cancer doctors

Kidney Cancer Treatment

Question: what is best treatment for kidney cancer that has spread to liver? Hi my mum was diagnosed with kidney cancer in Dec 2007 and had her right kidney removed Jan 08, it was a stage 3 tumor and though they said it was very advanced they did not remove the lymph-nodes as they thought they were ok. In Nov 08 her ct scan was clear and in March 09 they scan showed a spot on her liver which was 1.5cm, she had a MRI and they referred her back to the oncologist who told us the cancer had spread. At present she is awaiting to see the surgeon in L'pool regarding having the left half of her liver removed, which we have been told is major op. My mum is not sure if she wants the op, for a few reasons 1 because she feels removing half the liver will not cure the cancer and as they feel its probably spread through the blood or lymph-nodes and she feels it will only be matter of time before it reappears. 2 because she has been told its a minimum of a 3 month recovery. Is it true that the cancer is likely to reappear even if the current spot is removed? And does anyone know about radiofrequeny treatment as she is very keen to try that as compared to major sugery it only takes about a wks recovery. Which has the best results, and if she had surery how long would the cancer stay away? Are we talking it could stay away years amd years, as the oncologest said kidney cancer is an aggesive cancer.

Answer: I'm sorry to hear about your mum's cancer. If the oncologist has told you that it has likely spread beyond the liver then it is probable that it will come back later. Radiation therapy only works when you know where the cancer is. It may get rid of the cancer in the liver, as surgery will, but it won't prevent another spreading. If your mother's fears are well founded about further metastasis then I can see her reasoning for wanting the least invasive procedure possible.


Kidney Cancer Treatment News

Kuwait Times

Pfizer Wins U.S. Approval for Advanced Kidney-Cancer Treatment Inlyta
Bloomberg
 

Advances and New Research in the Treatment of Kidney Cancer

Cancer Network
Dr. Atkins, who has extensive clinical experience in kidney cancer and development of various new treatments, is presenting this weekend during the renal cancer translational science session at the American Society of Clinical Oncology 2012 ...
 

Another Year, Another High...

NASDAQ
Ariad's out-licensed product candidate Ridaforolimus is under development for multiple oncology indications, including soft tissue/bone sarcomas, endometrial cancer, breast cancer, lung and colon cancers, ovarian cancers and kidney cancer.
 

Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With ...

MarketWatch (press release)
Toni K. Choueiri, MD, Director of the Kidney Cancer Center at the Dana-Farber Cancer Institute, will present the data (Abstract #364) in a poster session at the 2012 Genitourinary Cancers Symposium at 6:45 am PST tomorrow in San Francisco.
 

Chronic Kidney Disease Linked to Higher Risk of Kidney and Urinary Tract Cancer

HealthCanal.com
Chronic kidney disease is associated with a higher risk of kidney and urothelial cancer, but not other types of cancer, according to research being presented this week at the American Society of Clinical Oncology's Genitourinary Cancers Symposium in ...
 

Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With ...

EON: Enhanced Online News (press release)
Toni K. Choueiri, MD, Director of the Kidney Cancer Center at the Dana-Farber Cancer Institute, will present the data (Abstract #364) in a poster session at the 2012 Genitourinary Cancers Symposium at 6:45 am PST tomorrow in San Francisco.
 

Kidney cancer drug adds options

Newsworks.org
By Taunya English A new kidney cancer drug is widening treatment options for patients who have disease that has spread to other parts of the body. Doctors say ten years ago they had very limited tools to battle advanced kidney cancer.
 

Health survey underway in Pompton Lakes

NorthJersey.com
In late 2009, a DHSS analysis revealed that there were elevated rates of kidney cancer among women and non-Hodgkin's lymphoma among men who lived above the local contaminated groundwater between 1979 and 2006. DuPont contaminated the area when it ...
 

New Oral Kinase Inhibitor Axitinib Approved for Advanced Renal Cancer

Pharmacy Practice News
The FDA has approved the oral kinase inhibitor axitinib (Inlyta, Pfizer) for treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy, according to press releases from the FDA and Pfizer.
 

Cabozantinib Shows Encouraging Activity In Heavily Pretreated Patients With ...

TheStreet.com (press release)
Toni K. Choueiri, MD, Director of the Kidney Cancer Center at the Dana-Farber Cancer Institute, will present the data (Abstract #364) in a poster session at the 2012 Genitourinary Cancers Symposium at 6:45 am PST tomorrow in San Francisco.
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer